Logo - springer
Slogan - springer

| Pharmaceutical Medicine – incl. option to publish open access (Editorial Board)

Pharmaceutical Medicine

Pharmaceutical Medicine

Editor: Susan Pochon

ISSN: 1178-2595 (print version)
ISSN: 1179-1993 (electronic version)

Journal no. 40290

Editor (Adis International Limited, Auckland, New Zealand):

Sue Pochon

Section Editors (Adis International Limited, Auckland, New Zealand):

Martin Chopra

Alison Fitches

Kathy Fraser

Rod McNab

Kate Palmer

Omesha Perera

Dene Peters

Amitabh Prakash

David Williamson

Editors Emeriti:

Professor Anthony W. Fox, MSc MBBS MD FFPM FRCP DipPharmMed MCSFS DipFHI MFMLM CBiol. King's College London, London, England

Dr Shaun Kilminster, BSc(Hon) PGCEd MSc(Psych) CPsychol PhD FSS Hon FFPM. Institute of Naval Medicine, Alverstoke, England

Dr Robert N. Smith, BSc MD FRCP FFPM. St Ippolytis, Hitchin, England

Dr Noel Snell, FRCP FFPM FRIPH FIBiol. National Heart & Lung Institute, London, England

Editorial board members:

Dr Peter R. Arlett, MD MRCP. European Medicines Agency, London, England

Dr John F. Beary III, MD FACP. University of Cincinnati, Cincinnati, OH, USA

Dr Sander Becker, MD. Consultants in Pharmaceutical Medicine, Rose Bay North, NSW, Australia

Dr Ambrogio Bottoni, MD. Pfizer Inc., Milan, Italy

Dr Torbjӧrn Callréus, MD PhD. University of Copenhagen, Copenhagen, Denmark

Dr Norbert Clemens, MD PhD CPI. Association of Clinical Research Professionals Board of Trustees, Heidelberg, Germany

Mr Francis P. Crawley, PhL. Good Clinical Practice Alliance – Europe, Brussels, Belgium

Dr Jean-Paul Deslypere, MD PhD. Council on Education in Pharmaceutical Medicine, Singapore

Dr Francesco De Tomasi, MD. Scientific Society for Applied Research, Milan, Italy

Professor Stephen J.W. Evans, BA MSc FRCP FISPE Hon. FRCP. London School of Hygiene and Tropical Medicine, London, England

Dr Georg Ferber, PhD. Statistik Georg Ferber GmbH, Riehen, Switzerland

Professor Sanjay K. Garg, PhD. University of South Australia, Adelaide, SA, Australia

Dr E. Stewart Geary, MD. Eisai Co. Ltd., Tokyo, Japan

Mr Kenneth A. Getz, MBA. Tufts University Medical School, Boston, MA, USA

Mr Ari Gnanasakthy, BSc MSc MBA.  RTI Health Solutions, Research Triangle Park, NC, USA

Dr Ulrich Granzer, PhD. Granzer Regulatory Consulting & Services, Munich, Germany

Professor Jan D. Hirsch, BSPharm PhD. University of California, Irvine, CA, USA

Mr Alan Hunter, LLB BPharm. Independent Pharmaco-Legal Adviser, Staines, England

Dr Greg Koski, MD PhD CPI.  Alliance for Clinical Research Excellence and Safety, Cambridge, MA, USA

Dr Marlene Llopíz Avíles, BA MD MPH. Association of Medical Specialists in the Pharmaceutical Industry, Mexico City, Mexico

Dr Marcelo Marotti, MD PhD. AstraZeneca UK Ltd., Macclesfield, England

Dr Shunsuke Ono, PhD. University of Tokyo, Tokyo, Japan

Professor Sir Michael Rawlins, BSc MD FRCP FFPM. Medicines and Healthcare Products Regulatory Agency, London, England

Dr Klaus Rose, MD MS. Klausrose Consulting, Riehen, Switzerland

Professor Sam Salek, BPharm PhD RPh MRPSGB FFPM FESCP. University of Hertfordshire, Hatfield, England

Professor Grannum R. Sant, MD FRCS FACS. Tufts University School of Medicine, Boston, MA, USA

Dr Ruth Savage, MB BS MSc. University of Otago, Dunedin, New Zealand

Dr Johanna A. Schenk, MD FFPM DipPharmMed DGPharMed. PPH plus GmbH & Co. KG, Frankfurt/Main, Germany

Dr Jeffrey W. Sherman, MD FACP. Horizon Pharma, Deerfield, IL, USA

Dr Honorio Silva, MD. International Federation of Associations of Pharmaceutical Physicians and Pharmaceutical Medicine, New York, NY, USA

Dr Almath Spooner, PhD. Health Products Regulatory Agency, Dublin, Ireland

Professor Peter D. Stonier, BA BSc PhD MB ChB MRCPsych FRCP FRCPE FFPM. King’s College London, London, England

Dr Robert Temple, MD. Center for Drug Evaluation & Research, Food and Drug Administration, Rockville, MD, USA

Professor Stuart R. Walker, BSc PhD CChem CBiol FRSC FIBiol FInstD FRCPath. Centre for Innovation in Regulatory Science, Carshalton, England

Read this Journal on Springerlink

For authors and editors

  • Aims and Scope

    Aims and Scope


    Pharmaceutical Medicine is a specialist discipline concerned with medical aspects of the discovery, development, evaluation, registration, regulation, monitoring, marketing, distribution and pricing of medicines, drug-device and drug-diagnostic combinations. The Journal disseminates information to support the community of professionals working in these highly inter-related functions. Key areas include translational medicine, clinical trial design, pharmacovigilance, clinical toxicology, drug regulation, clinical pharmacology, biostatistics and pharmacoeconomics.

    The Journal includes:

    • Overviews of contentious or emerging issues.
    • Comprehensive narrative reviews that provide an authoritative source of information on topical issues.
    • Systematic reviews that collate empirical evidence to answer a specific research question, using explicit, systematic methods as outlined by PRISMA statement.
    • Original research articles reporting the results of well-designed studies with a strong link to wider areas of clinical research.

    Additional enhanced features (including slide sets, videos and animations) can be published with articles; these are designed to increase the visibility, readership and educational value of the journal’s content. In addition, articles published in Pharmaceutical Medicine may be accompanied by plain language summaries to assist patients, caregivers and others in understanding important medical advances. All enhanced features are peer reviewed to the same high standard as the article itself.

    All manuscripts are subject to peer review by international experts. Letters to the Editor are welcomed and will be considered for publication.

  • Submit Online
  • Open Choice - Your Way to Open Access
  • Instructions for Authors

    Instructions for Authors


  • Ethical Guidelines (pdf, 219 kB)
  • Additional Information for Authors (docx...
  • Conflict of Interest form (doc, 84 kB)
  • Copyright Information

    Copyright Information


    Copyright Information

    For Authors

    Submission of a manuscript implies: that the work described has not been published before (except in form of an abstract or as part of a published lecture, review or thesis); that it is not under consideration for publication elsewhere; that its publication has been approved by all co-authors, if any, as well as – tacitly or explicitly – by the responsible authorities at the institution where the work was carried out.

    Author warrants (i) that he/she is the sole owner or has been authorized by any additional copyright owner to assign the right, (ii) that the article does not infringe any third party rights and no license from or payments to a third party is required to publish the article and (iii) that the article has not been previously published or licensed. The author signs for and accepts responsibility for releasing this material on behalf of any and all co-authors. Transfer of copyright to Springer (respective to owner if other than Springer) becomes effective if and when a Copyright Transfer Statement is signed or transferred electronically by the corresponding author. After submission of the Copyright Transfer Statement signed by the corresponding author, changes of authorship or in the order of the authors listed will not be accepted by Springer.

    The copyright to this article, including any graphic elements therein (e.g. illustrations, charts, moving images), is assigned for good and valuable consideration to Springer effective if and when the article is accepted for publication and to the extent assignable if assignability is restricted for by applicable law or regulations (e.g. for U.S. government or crown employees).

    The copyright assignment includes without limitation the exclusive, assignable and sublicensable right, unlimited in time and territory, to reproduce, publish, distribute, transmit, make available and store the article, including abstracts thereof, in all forms of media of expression now known or developed in the future, including pre- and reprints, translations, photographic reproductions and microform. Springer may use the article in whole or in part in electronic form, such as use in databases or data networks for display, print or download to stationary or portable devices. This includes interactive and multimedia use and the right to alter the article to the extent necessary for such use.

    Authors may self-archive the Author's accepted manuscript of their articles on their own websites. Authors may also deposit this version of the article in any repository, provided it is only made publicly available 12 months after official publication or later. He/she may not use the publisher's version (the final article), which is posted on SpringerLink and other Springer websites, for the purpose of self-archiving or deposit. Furthermore, the Author may only post his/her version provided acknowledgement is given to the original source of publication and a link is inserted to the published article on Springer's website. The link must be accompanied by the following text: "The final publication is available at link.springer.com".

    Prior versions of the article published on non-commercial pre-print servers like arXiv.org can remain on these servers and/or can be updated with Author's accepted version. The final published version (in pdf or html/xml format) cannot be used for this purpose. Acknowledgement needs to be given to the final publication and a link must be inserted to the published article on Springer's website, accompanied by the text "The final publication is available at link.springer.com". Author retains the right to use his/her article for his/her further scientific career by including the final published journal article in other publications such as dissertations and postdoctoral qualifications provided acknowledgement is given to the original source of publication.

    Author is requested to use the appropriate DOI for the article. Articles disseminated via link.springer.com are indexed, abstracted and referenced by many abstracting and information services, bibliographic networks, subscription agencies, library networks, and consortia.

    For Readers

    While the advice and information in this journal is believed to be true and accurate at the date of its publication, neither the authors, the editors, nor the publisher can accept any legal responsibility for any errors or omissions that may have been made. The publisher makes no warranty, express or implied, with respect to the material contained herein.

    All articles published in this journal are protected by copyright, which covers the exclusive rights to reproduce and distribute the article (e.g., as offprints), as well as all translation rights. No material published in this journal may be reproduced photographically or stored on microfilm, in electronic data bases, video disks, etc., without first obtaining written permission from the publisher (respective the copyright owner if other than Springer). The use of general descriptive names, trade names, trademarks, etc., in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.

    Springer has partnered with Copyright Clearance Center's RightsLink service to offer a variety of options for reusing Springer content. For permission to reuse our content please locate the material that you wish to use on link.springer.com or on springerimages.com and click on the permissions link or go to copyright.com, then enter the title of the publication that you wish to use. For assistance in placing a permission request, Copyright Clearance Center can be connected directly via phone: +1-855-239-3415, fax: +1-978-646-8600, or e-mail: info@copyright.com.

    © Springer International Publishing Switzerland

Alerts for this journal


Get the table of contents of every new issue published in Pharmaceutical Medicine.